Epigenomic biomarkers of cardiometabolic disease: How far are we from daily practice?
Abstract Determining whether someone has cardiometabolic disease (CMD), especially in the early stages, can be complicated. Risk stratification ordinarily depends on an extended process relying on medical history that typically considers blood pressure, cholesterol, smoking and diabetes status. Phys...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Cardiovascular Diabetology |
| Online Access: | https://doi.org/10.1186/s12933-024-02497-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|